AN2 Therapeutics, Inc. · NASDAQ:ANTX

AN2 Therapeutics, Inc. shareholders

As of Sep 30, 2026, 84 institutions reported holding AN2 Therapeutics, Inc., 70.9% of its shares. Largest: Vivo Capital, LLC, Commodore Capital LP and Millennium. New holders, exits, insiders and big stakes, each with its filing.

HolderShares% of AN2 Therapeutics, Inc.ChangeFiled
Vivo Capital, LLC3.15M8.3%no changeNov 13, 2026
Commodore Capital LP2.93M7.7%no changeNov 16, 2026
Millennium2.48M6.5%+158KNov 16, 2026
BlackRock1.77M4.7%+106KNov 13, 2026
Spruce Street Capital LP1.75M4.6%+90,938Nov 13, 2026
Vanguard1.63M4.3%+6,381Nov 13, 2026
Acorn Capital Advisors, LLC1.3M3.4%newNov 16, 2026
Adage Capital Partners Gp, L.L.C.1M2.6%no changeNov 16, 2026
Citadel984K2.6%+32,083Nov 16, 2026
Boxer Capital Management, LLC944K2.5%+195KNov 16, 2026

AN2 Therapeutics, Inc. insider trades